ALLENA PHARMACEUTICALS, INC. — Operating Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/dbd71631-d7dc-4edd-9923-f0a5621074d2/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-47.6M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-005192 |
| FY 2020 | $-32.0M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-012238 |
| FY 2019 | $-47.5M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-010991 |
| FY 2018 | $-35.6M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-006630 |
| FY 2017 | $-20.9M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-006811 |
| FY 2016 | $-24.2M | 2016-01-01 – 2016-12-31 | evidence 0001564590-18-006811 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).